Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP): A Phase Ib/II Open-Label Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07477418
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:12.763849+00:00
Published At
2026-03-17T00:00:00+00:00
Record Updated At
2026-03-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Pancreatic Ductal Adenocarcinoma (PDAC)", "Borderline Resectable Pancreatic Cancer", "Pancreatic Neoplasms"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-17"
protocolSection.identificationModule.nctId
"NCT07477418"
protocolSection.identificationModule.officialTitle
"PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP): A Phase Ib/II Open-Label Trial"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Pancreatic Ductal Adenocarcinoma (PDAC) (protocolSection.conditionsModule.conditions)
  • Borderline Resectable Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • Pancreatic Neoplasms (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.